Dramatic parotid uptake of I-131 on a diagnostic whole-body scan

被引：10

作者：

Carlisle, MR ^{[1
]}

McDougall, IR ^{[1
]}

机构：

[1] Standford Hlth Serv, Div Nucl Med, Stanford, CA 94305 USA

来源：

CLINICAL NUCLEAR MEDICINE | 2000年 / 25卷 / 11期

关键词：

I-131; scintigraphy; radiation sialadenitis;

D O I：

10.1097/00003072-200011000-00007

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Radiation sialadenitis is a complication of I-131 therapy for thyroid cancer. They authors report a case of intense uptake by parotid glands in a diagnostic I-131 scan (2 mCi) in whom sialadenitis had developed previously after a 100-mCi dose of I-131. Similar examples of images could not be found in the literature.

引用

页码：895 / 897

页数：3

共 12 条

[1]

ALLWEISS P, 1984, J NUCL MED, V25, P755

[2] FALSE-POSITIVE RADIOIODINE WHOLE-BODY SCAN IN THYROID-CANCER PATIENTS DUE TO UNRELATED PATHOLOGY [J].

BAKHEET, SM ;

HAMMAMI, MM .

CLINICAL NUCLEAR MEDICINE, 1994, 19 (04) :325-329

[3]

Bohuslavizki KH, 1998, J NUCL MED, V39, P1237

[4]

Doniach I., 1978, THYROID, P274

[5] THE USE OF RADIOACTIVE IODINE IN THYROID-CARCINOMA [J].

GOOLDEN, AWG .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02) :339-343

[6] RADIATION SIALITIS FOLLOWING RADIOIODINE THERAPY [J].

GOOLDEN, AWG ;

MALLARD, JR ;

FARRAN, HEA .

BRITISH JOURNAL OF RADIOLOGY, 1957, 30 (352) :210-212

[7] SIALADENITIS MIMICKING METASTATIC THYROID-CARCINOMA [J].

KOLLA, IS ;

ALAZRAKI, NP ;

WATTS, NB .

CLINICAL NUCLEAR MEDICINE, 1989, 14 (08) :564-566

[8] EFFECT OF RADIOACTIVE IODINE THERAPY ON PAROTID-GLAND FUNCTION [J].

MAIER, H ;

BIHL, H .

ACTA OTO-LARYNGOLOGICA, 1987, 103 (3-4) :318-324

[9] WHOLE-BODY SCINTIGRAPHY WITH RADIOIODINE-131 - A COMPREHENSIVE LIST OF FALSE-POSITIVES WITH SOME EXAMPLES [J].

MCDOUGALL, IR .

CLINICAL NUCLEAR MEDICINE, 1995, 20 (10) :869-875

[10] 74 MBq radioiodine I-131 does not prevent uptake of therapeutic doses of I-131 (ie it does not cause stunning) in differentiated thyroid cancer [J].

McDougall, IR .

NUCLEAR MEDICINE COMMUNICATIONS, 1997, 18 (06) :505-512

← 1 2 →